News Articles for Patrick Moase

Orthocell has finalised a move to boost its stake in Marine Biomedical, the company developing a bone substitute using Kimberley pearls, simultaneously securing global distribution rights.

Marine Biomedical is giving pearling waste a new lease on life as an innovative bone repair product.

Medical implants and waste reduction are among the local uses for technology derived from the sea.